Idera Pharmaceuticals
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income dropped to -$23,360,000 over the previous period. Total operating expenses were $32,680,000.

Profit Margin

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA): Profit margin
2013 47K -18.22M -38778.72%
2014 73K -38.64M -52934.25%
2015 249K -48.55M -19500%
2016 16.19M -38.38M -236.98%
2017 902K -65.98M -7315.3%
2018 662K -59.88M -9045.47%
2019 1.44M -56.51M -3902.97%
2020 0 -112.66M
2021 0 98.08M
2022 0 -23.36M

IDRA Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
0001.44M662K902K16.19M249K73K47K
Cost of revenue
0000000000
Gross profit
0001.44M662K902K16.19M249K73K47K
Operating exp.
Research and development
12.18M16.37M24.77M34.85M41.84M50.65M39.82M33.69M27.49M10.47M
Selling and marketing
0000000000
Total operating expenses
32.68M27.67M36.68M47.33M57.26M67.36M54.95M49.09M38.82M18.21M
Operating income
-29.47M98.09M-36.68M-46.06M-60.95M-66.46M-38.75M-48.84M-38.75M-18.16M
Other income (expenses), net
-204K-7K-75.97M-10.44M1.07M483K368K291K110K-57K
Income before tax
-29.67M98.09M-112.66M-56.51M-59.88M-65.98M-38.38M-48.55M-38.64M-18.22M
Income tax expense
-6.31M7K-75.97M-10.44M1.08M533K448K396K110K-57K
Net income
-23.36M98.08M-112.66M-56.51M-59.88M-65.98M-38.38M-48.55M-38.64M-18.22M
Earnings per share
Basic EPS
-7.1849.3-56.63-33.66-38.27-57.01-40.92-57.38-63.45-56.46
Diluted EPS
-7.1849.3-56.63-33.66-38.27-57.01-40.92-57.38-63.45-56.46
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source